μCaler EMS Panel
Methylation & mutation detection across 9 cancers
CommercialActive
Key Facts
Indication
Methylation & mutation detection across 9 cancers
Phase
Commercial
Status
Active
Company
About Nanodigmbio
A Singapore‑based NGS diagnostics platform delivering ultra‑sensitive, rapid targeted sequencing solutions for oncology and infectious disease.
View full company profile